Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Certa Plans Pivotal Scleroderma Trial As GPCR Antagonist Hits Phase II Bullseye
Australian Firm Has High Hopes
Feb 07 2023
•
By
Ayisha Sharma
Scleroderma Causes Hardened, Thickened Skin And Muscle Weakness • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D